Literature DB >> 33821822

Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed.

Kim Anderson1, Emma Kalk1, Hlengiwe P Madlala2, Dorothy C Nyemba1,2, Nisha Jacob3, Amy Slogrove4, Mariette Smith1,5, Max Kroon6, Michael C Harrison6, Brian S Eley7, Andrew Boulle1,3,5, Landon Myer2, Mary-Ann Davies1,3,5.   

Abstract

OBJECTIVES: Infants who are HIV exposed but uninfected (HEU) compared with HIV unexposed uninfected (HUU) have an increased risk of adverse birth outcomes, morbidity and hospitalization. In the era of universal maternal antiretroviral treatment, there are few insights into patterns of neonatal morbidity specifically.
DESIGN: A prospective cohort study.
METHODS: We compared neonatal hospitalizations among infants who were HEU (n = 463) vs. HUU (n = 466) born between 2017 and 2019 to a cohort of pregnant women from a large antenatal clinic in South Africa. We examined maternal and infant factors associated with hospitalization using logistic regression.
RESULTS: Hospitalization rates were similar between neonates who were HEU and HUU (13 vs. 16%; P = 0.25). Overall, most hospitalizations occurred directly after birth (87%); infection-related causes were identified in 34%. The most common reason for hospitalization unrelated to infection was respiratory distress (25%). Very preterm birth (<32 weeks) (29 vs. 11%; P = 0.01) as well as very low birthweight (<1500 g) (34 vs. 16%; P = 0.02) occurred more frequently among hospitalized neonates who were HEU. Of those hospitalized, risk of intensive care unit (ICU) admission was higher in neonates who were HEU (53%) than HUU (27%) [risk ratio = 2.1; 95% confidence interval (95% CI) 1.3-3.3]. Adjusted for very preterm birth, the risk of ICU admission remained higher among neonates who were HEU (aRR = 1.8; 95% CI 1.1-2.9).
CONCLUSION: Neonates who were HEU (vs. HUU) did not have increased all-cause or infection-related hospitalization. However, very preterm birth, very low birthweight and ICU admission were more likely in hospitalized neonates who were HEU, indicating increased severity of neonatal morbidity.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33821822      PMCID: PMC8076534          DOI: 10.1097/QAD.0000000000002856

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  43 in total

Review 1.  A review and analysis of intensive care medicine in the least developed countries.

Authors:  Martin W Dünser; Inipavudu Baelani; Lundeg Ganbold
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

2.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

3.  Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.

Authors:  Thokozile R Malaba; Tamsin Phillips; Stanzi Le Roux; Kirsty Brittain; Allison Zerbe; Greg Petro; Agnes Ronan; James A McIntyre; Elaine J Abrams; Landon Myer
Journal:  Int J Epidemiol       Date:  2017-10-01       Impact factor: 7.196

4.  Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

Authors:  Kathleen M Powis; Douglas Kitch; Anthony Ogwu; Michael D Hughes; Shahin Lockman; Jean Leidner; Erik van Widenfelt; Claire Moffat; Sikhulile Moyo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

5.  Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?

Authors:  Louise Kuhn; Prisca Kasonde; Moses Sinkala; Chipepo Kankasa; Katherine Semrau; Nancy Scott; Wei-Yann Tsai; Sten H Vermund; Grace M Aldrovandi; Donald M Thea
Journal:  Clin Infect Dis       Date:  2005-10-27       Impact factor: 9.079

6.  Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.

Authors:  Nan Li; Mary Mwanyika Sando; Donna Spiegelman; Ellen Hertzmark; Enju Liu; David Sando; Lameck Machumi; Guerino Chalamilla; Wafaie Fawzi
Journal:  J Infect Dis       Date:  2015-08-10       Impact factor: 5.226

7.  Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study.

Authors:  Amy L Slogrove; Kathleen M Powis; Leigh F Johnson; John Stover; Mary Mahy
Journal:  Lancet Glob Health       Date:  2019-11-29       Impact factor: 26.763

8.  HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.

Authors:  Ceri Evans; Jean H Humphrey; Robert Ntozini; Andrew J Prendergast
Journal:  Front Immunol       Date:  2016-06-06       Impact factor: 7.561

9.  Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.

Authors:  Erick Sell; Flor M Munoz; Aung Soe; Max Wiznitzer; Paul T Heath; E D Clarke; Hans Spiegel; Daphne Sawlwin; Maja Šubelj; Ilia Tikhonov; Khorshid Mohammad; Sonali Kochhar
Journal:  Vaccine       Date:  2017-12-04       Impact factor: 3.641

10.  Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa.

Authors:  A Boulle; A Heekes; N Tiffin; M Smith; T Mutemaringa; N Zinyakatira; F Phelanyane; C Pienaar; K Buddiga; E Coetzee; R van Rooyen; R Dyers; N Fredericks; A Loff; L Shand; M Moodley; I de Vega; K Vallabhjee
Journal:  Int J Popul Data Sci       Date:  2019-11-20
View more
  1 in total

1.  Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya: protocol for a prospective cohort study (Tabiri Study).

Authors:  Eren Oyungu; Ola El Kebbi; Rachel Vreeman; Winstone Nyandiko; Patrick O Monahan; Wanzhu Tu; Alka Khaitan; Zeruesenay Desta; Amy L Slogrove; John M Humphrey; Edwin Were; Rena C Patel; James G Carlucci; Kara Wools-Kaloustian; Megan S McHenry
Journal:  BMJ Open       Date:  2022-04-04       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.